Navigation Links
DIA Conference to Provide FDA, EMEA, Health Canada, Emerging Regions, NGO, and Industry Perspectives on Global Vaccine Development
Date:9/29/2009

The Drug Information Association (DIA) will present FDA, EMEA, Health Canada, emerging region, NGO, and industry perspectives on Global Vaccine Development at the Global Vaccine Development for World Health Symposium from November 3-4 in Bethesda, MD.

Horsham, PA (Vocus) -- The Drug Information Association (DIA) will present FDA, EMEA, Health Canada, emerging region, NGO, and industry perspectives on Global Vaccine Development at the Global Vaccine Development for World Health Symposium from November 3-4 in Bethesda, MD. This two-day symposium will address the regulatory pathways for the development of global vaccines to treat infectious diseases such as tuberculosis, malaria and H1N1.

Representatives and regulatory experts from the US Food and Drug Administration (FDA), World Health Organization (WHO), Bill & Melinda Gates Foundation, International Vaccine Initiative (IVI), Developing Countries Regulatory Network (DCRN), and BIO Ventures for Global Health (BVGH) will discuss strategies for the development and regulation of preventative vaccines for global diseases. Special emphasis will be given to the WHO prequalification process and FDAAA voucher program relative to global vaccine development for world health. Session topics will include:

 
  • Regulatory Approaches and Pathways for Global Vaccine Development: FDA, EMEA, Emerging Regions and Industry Perspectives
  • Prequalification of Global Vaccines
  • Special Presentation on Ethical Considerations in Global Vaccine Development
  • Novel Approaches to Global Vaccine Development
  • Global Vaccine Development: Path Forward and Open Dialogue
  • Speakers will include:
  • Norman Baylor, PhD, Director, Office of Vaccines Research & Review (OVRR), CBER, FDA
  • David Wood, PhD, Coordinator of the Quality, Safety & Standards Team of the Department of Immunization, Vaccines & Biologicals, WHO
  • Vincent Ahonkhai, MD: Senior Regulatory Officer, Global Health Delivery, Bill and Melinda Gates Foundation
  • Christine Grady, MSN, PhD, Head Section on Human Subjects Research, Department of Bioethics, National Institutes of Health Clinical Center
Jesse Goodman, MD, MPH, Acting Chief Scientist & Deputy Commissioner for Scientific & Medical Programs for FDA, will deliver the keynote address.

"In September 2008 the Center for Biologics Evaluation and Research (CBER) at the US Food and Drug Administration (FDA) published an important FDA Guidance Document that will expand the FDA's role in facilitating the development of new vaccines for global bacterial, viral, and parasitic diseases affecting millions of people in developing countries worldwide," explains Program Co-chair Michael Brennan, PhD, Senior Advisor for Global Affairs, Aeras Global TB Vaccine Foundation. "This symposium will explore this new guidance in depth and discuss the necessary paths to develop vaccines for global diseases."

Click here to register.

About the Drug Information Association (DIA)
DIA serves more than 30,000 professionals involved in the biopharmaceutical industry and regulatory affairs worldwide. Through its domestic and international meetings, training courses, workshops and webinars, DIA provides a neutral global forum for the exchange of information critical to the advancement of the drug discovery and lifecycle management processes. Headquartered in Horsham, PA, USA, and with offices in Basel, Switzerland, Tokyo, Japan, Mumbai, India, and Beijing, China, the Association is led by its volunteer-based Board of Directors and executive management team. For more information, visit www.diahome.org or call 215-442-6100.


Contact: Joe Krasowski
DIA
+1-215-293-5812

###

Read the full story at http://www.prweb.com/releases/2009/09/prweb2963384.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Related biology technology :

1. Imagenetix Inc. to Present at Noble Small Cap Financial Conference on August 21, 2007
2. Anesiva to Host Conference Call and Webcast Tomorrow to Discuss Encouraging Development in Zingo(TM) Program
3. Avicena Group to Present at Noble Financial Conference
4. Strategic Diagnostics to Present at Two Upcoming Investor Conferences
5. Intellect Neurosciences, Inc. to Present Data on Alzheimers Vaccine at 13th International Congress of Immunology Conference
6. CEL-SCI to Present at the Noble Financial Conference
7. NuVasive to Present at Thomas Weisel Partners Healthcare Conference
8. ZymoGenetics Will Hold Conference Call Today at 5:00 p.m. Eastern Time to Provide Update on rThrombin
9. Strategic Diagnostics Updates Roth Conference Presentation Time
10. Monogram Biosciences to Present at the Thomas Weisel Partners Healthcare Conference 2007
11. Nabi Biopharmaceuticals to Present at Upcoming Industry Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
DIA Conference to Provide FDA, EMEA, Health Canada, Emerging Regions, NGO, and Industry Perspectives on Global Vaccine Development
(Date:4/29/2016)... 2016 According to a ... "Separation Systems for Commercial Biotechnology Market - Global ... 2015 - 2023", the separation systems for commercial ... in 2014 and is projected to expand at ... to reach US$ 19,227.8 Mn in 2023. ...
(Date:4/28/2016)... PUNE, India , April 28, 2016 ... PT, JT, Stirling, and Brayton Cryocoolers), Service (Technical Support, ... Application, and Geography - Global Forecast to 2022", published ... to USD 2.94 Billion by 2022, at a CAGR ... Browse 70 market data Tables and 94 Figures spread ...
(Date:4/28/2016)... ... April 28, 2016 , ... Morris Midwest ... house for regional manufacturers at its Maple Grove, Minnesota technical center, May 11-12. ... Chiron and Trumpf. Almost 20 leading suppliers of tooling, accessories, software and ...
(Date:4/27/2016)... , April 27, 2016 ... (CSE: NSK) (OTCPink: NSKQB) ( Frankfurt ... an ihre Pressemitteilung vom 13. August 2015 die ... ihre Finanzen um zusätzliche 200.000.000 Einheiten auf 400.000.000 ... Dollar zu bringen. Davon wurden 157.900.000 Einheiten mit ...
Breaking Biology Technology:
(Date:4/14/2016)... April 14, 2016 BioCatch ... Detection, today announced the appointment of Eyal Goldwerger ... role. Goldwerger,s leadership appointment comes at a ... of the deployment of its platform at several of ... technology, which discerns unique cognitive and physiological factors, is ...
(Date:3/29/2016)... 2016 LegacyXChange, Inc. (OTC: ... SelectaDNA/CSI Protect are pleased to announce our successful effort ... variety of writing instruments, ensuring athletes signatures against counterfeiting ... from athletes on LegacyXChange will be assured of ongoing ... Bill Bollander , CEO states, "By ...
(Date:3/21/2016)... Unique technology combines v ... security   Xura, Inc. ... digital communications services, today announced it is working alongside ... customers, particularly those in the Financial Services Sector, the ... within a mobile app, alongside, and in combination with, ...
Breaking Biology News(10 mins):